Who is sponsoring NCT05804500?

NCT05804500 is sponsored by NODEHealth Foundation.

What drugs are being tested in NCT05804500?

Interventions in NCT05804500: Cardiac Telerehabilitation (CTR) via the RecoveryPlus platform.

What condition does NCT05804500 study?

NCT05804500 studies Heart Diseases, Angina, Stable, Angina Pectoris, Myocardial Ischemia, Myocardial Infarction, Coronary Artery Disease, Coronary Artery Stenosis, Valve Heart Disease, Valve Disease, Heart.

Is NCT05804500 still recruiting?

NCT05804500 is currently completed. Last updated 19 January 2024.

Last reviewed 2024-01-19 · How we verify

NCT05804500

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RecoveryPlus Telerehab Platform Pilot Study

Completed NA Last updated 19 January 2024

What this trial tests

NA trial testing Cardiac Telerehabilitation (CTR) via the RecoveryPlus platform in Heart Diseases in 75 participants. Completed in 15 January 2024.

Timeline

27 March 2023

Primary endpoint
31 December 2023

15 January 2024

Quick facts

Lead sponsor	NODEHealth Foundation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	75
Start date	27 March 2023
Primary completion	31 December 2023
Estimated completion	15 January 2024
Sites	1 location across United States

Drugs / interventions tested

Cardiac Telerehabilitation (CTR) via the RecoveryPlus platform

Conditions studied

Heart Diseases — all drugs for Heart Diseases →
Angina, Stable — all drugs for Angina, Stable →
Angina Pectoris — all drugs for Angina Pectoris →
Myocardial Ischemia — all drugs for Myocardial Ischemia →

Sponsor

NODEHealth Foundation

Who can join

45 and older, any sex, with Heart Diseases or Angina, Stable. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective, single-arm study, we will look at the initiation, participation, sustained engagement, and safety of 100 adult subjects (ages 45 years or older) with recent (within the past 60 days) clinician referral to CR who are offered CTR via the RecoveryPlus platform. We want to understand the effectiveness of the RecoveryPlus platform in engaging participants in CR while remaining a safe alternative for the delivery of evidence-based CR content. The primary hypothesis of this study is that the RecoveryPlus CTR platform and patient-facing mobile application provide a safe alternative to traditional in-person CR, and demonstrate a high rate of initiation, participation, and engagement in CR exercise programming than traditional modes of CR delivery, as documented in the literature. Current in-person and non-personalized CR programming lacks RecoveryPlus' convenient remote access, easy-to-use digital tools to support independent, autonomous exercise, and a platform to facilitate engagement and feedback between patients and EPs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Dual-Modality Home-Based Cardiac Rehabilitation Program for Adults With Cardiovascular Disease: Single-Arm Remote Clinical Trial.
Bilbrey T, Martin J, Zhou W, Bai C, et al · · 2024 · cited 7× · PMID 39150858 · DOI 10.2196/59098

Verify or expand the search:

Other recruiting trials for Heart Diseases

Currently open trials in the same condition.

NCT07288216 — Transition to KPL-387 Monotherapy Dosing & Administration Study · Phase 2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
NCT06769880 — Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Fa · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05804500 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NODEHealth Foundation
Last refreshed: 19 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05804500.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing